Pacira BioSciences, Stock Target Price and Analyst Consensus
| PCRX Stock | USD 21.09 0.68 3.12% |
The current analyst and expert consensus on Pacira BioSciences, is Buy, with only one strong buy opinion. The current projected Pacira BioSciences, target price consensus is 30.40 with 6 analyst opinions. Check out Macroaxis Advice on Pacira BioSciences, to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.The most common way Pacira BioSciences, analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Pacira BioSciences, executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Pacira BioSciences,. We strongly encourage you to use your own analysis of Pacira BioSciences, to validate this buy or sell advice. Pacira BioSciences, buy-or-sell recommendation module provides average expert sentiment on the projected Pacira BioSciences, target price to derive its highest and lowest estimates based on projected price volatility of 2.0278.
Lowest Forecast 27.66 | Highest Forecast 33.74 | Target Price 30.4 |
It's important to approach Pacira BioSciences,'s target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Pacira BioSciences, Target Price Consensus
Pacira target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Pacira BioSciences,'s target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Buy |
Most Pacira analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Pacira stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Pacira BioSciences,, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPacira BioSciences, Target Price Projection
Pacira BioSciences,'s current and average target prices are 21.09 and 30.40, respectively. The current price of Pacira BioSciences, is the price at which Pacira BioSciences, is currently trading. On the other hand, Pacira BioSciences,'s target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Pacira BioSciences, Market Quote on 1st of August 2025
Target Price
Analyst Consensus On Pacira BioSciences, Target Price
Pacira BioSciences, Analyst Ratings
Pacira BioSciences,'s analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Pacira BioSciences, stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Pacira BioSciences,'s financials, market performance, and future outlook by experienced professionals. Pacira BioSciences,'s historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Pacira BioSciences, price targets
Pacira BioSciences,'s stock target price is an estimate of its future price, usually made by analysts. Using Pacira BioSciences,'s target price to determine if it is a suitable investment can be done through the following steps:- Look at Pacira BioSciences,'s target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Pacira BioSciences,'s stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Pacira BioSciences, Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Pacira BioSciences, is a key component of Pacira BioSciences, valuation and have some predictive power on the future returns of a Pacira BioSciences,.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Target Risk ETFs Invested over 200 shares | |
| Strategy ETFs Invested over 100 shares | |
 | Macroaxis Index Invested over 500 shares | |
| Investment Grade ETFs Invested over 400 shares | |
 | Real Estate Invested over 100 shares | |
Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.